@article{3d823eb8e91b44798e02a672c551207a,
title = "Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease",
keywords = "Crohn's Disease, Therapeutic Drug Monitoring, Infliximab, Mucosal Healing, INFLAMMATORY-BOWEL-DISEASE, SCHEDULED MAINTENANCE TREATMENT, RANDOMIZED-TRIAL, TROUGH LEVEL, ANTIBODIES, THERAPY, INTENSIFICATION, MULTICENTER, OUTCOMES",
author = "Geert D'Haens and Severine Vermeire and Guy Lambrecht and Filip Baert and Peter Bossuyt and Benjamin Pariente and Anthony Buisson and Yoram Bouhnik and Jerome Filippi and {Vander Woude}, Janneke and {Van Hootegem}, Philippe and Jacques Moreau and Edouard Louis and Denis Franchimont and {De Vos}, Martine and Fazia Mana and Laurent Peyrin-Biroulet and Hedia Brixi and Matthieu Allez and Philip Caenepeel and Alexandre Aubourg and Bas Oldenburg and Marieke Pierik and Ann Gils and Sylvie Chevret and David Laharie and GETAID",
year = "2018",
month = apr,
day = "1",
doi = "10.1053/j.gastro.2018.01.004",
language = "English",
volume = "154",
pages = "1343--1351.e1",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "Elsevier Saunders",
number = "5",
}